Royal Philips Acquires Vesper Medical from Gilde Healthcare

Philips Acquires Intact Vascular

August 27, 2020

Medical Devices

Royal Philips has signed an agreement to acquire Intact Vascular, a U.S.-based developer of the Tack Endovascular System, to expand Philips' image-guided therapy devices portfolio for peripheral artery disease. The deal includes USD 275 million upfront in cash plus deferred payments (up to ~USD 360 million total) and is expected to close in the third quarter of 2020, after which Intact Vascular will join Philips' Image-Guided Therapy business.

Stryker Acquires Vertos Medical Inc.

August 22, 2024

Medical Devices

Stryker has entered into a definitive agreement to acquire Vertos Medical Inc., a privately held company that develops the minimally invasive Mild® procedure for treating lumbar spinal stenosis. The acquisition expands Stryker’s interventional pain management and minimally invasive treatment portfolio and extends its reach into ambulatory surgery centers; the transaction remains subject to customary closing conditions.

Vesper Healthcare Acquisition Corp. Merges with The HydraFacial Company (BeautyHealth)

May 5, 2021

Healthcare Services

Vesper Healthcare Acquisition Corp. completed a business combination with The HydraFacial Company, taking the business public as The Beauty Health Company (ticker: SKIN) in a transaction that values HydraFacial at a pro forma enterprise value of $1.1 billion. The deal included a fully committed $350 million PIPE anchored by institutional investors (including Fidelity, Redmile, Principal, Camber and Woodline), and Linden Capital Partners and DW Healthcare Partners remain meaningful shareholders with management continuing in place.

Garmin Acquires Vesper Marine

January 3, 2022

Manufacturing

Garmin Ltd. has acquired Vesper Marine, a privately-held Auckland-based maker of AIS, VHF and vessel monitoring solutions, including the Cortex integrated communications system. The acquisition will expand Garmin's marine communications and situational awareness product portfolio; financial terms were not disclosed.

Royal Philips Acquires Capsule Technologies from Francisco Partners for $635M

January 19, 2021

Medical Devices

Royal Philips agreed to acquire Capsule Technologies, a portfolio company of Francisco Partners, for $635 million in cash. The deal will fold Capsule — a developer of medical device integration, patient monitoring, and clinical surveillance software used by hospitals worldwide — into Philips' Connected Care segment; Capsule has roughly 300 employees and serves more than 2,800 hospitals in 40 countries.

Haemonetics Acquires Vivasure Medical

January 11, 2026

Medical Devices

Haemonetics Corporation has acquired Galway-based Vivasure Medical in a transaction valued at up to €185 million, consisting of an upfront €100 million payment plus up to €85 million in contingent milestone payments. The acquisition adds Vivasure's PerQseal Elite fully bioabsorbable vascular closure system to Haemonetics' large-bore closure portfolio; Vivasure has CE Mark approvals and has submitted a PMA to the U.S. FDA.